• A new horizon

    The future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, however, we will see the dreamscape of an era-defining healthcare system and pharma industry, transformed by the stunning possibilities of AI

  • A new contract for integrated care

    Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems

  • The digitisation of regulatory affairs

    If information and process digitisation is as positively disruptive as its proponents claim, then what is the potential for transforming the management of marketing authorisation? Assuming this is considerable, what is involved in enabling practical, large-scale data management, and how can RA departments build on product data to help advance the broader business agenda?

News

View all

Web Exclusives

View all
Thumbnail image for Big pharma - come back to mental health and invest in Europe

Big pharma - come back to mental health and invest in Europe

As Mental Health Awareness Week 2019 begins (13/5/19), King’s College London Professor of Psychiatry Allan Young offers his thoughts on how a new European pharmacovigilance consortium could pave the way for new mental health drugs for UK patients.

Thumbnail image for SmartPeople: Jennifer Turgiss

SmartPeople: Jennifer Turgiss

Jennifer Turgiss provides an insight into her role as vice president, behaviour science and advanced analytics, at Johnson & Johnson

Thumbnail image for Class of 2019

Class of 2019

A high proportion of this year’s Drugs to Watch list address rare and orphan diseases

Thumbnail image for Mapping tumours – a new direction for cancer treatment

Mapping tumours – a new direction for cancer treatment

A team from the National Physical Laboratory (NPL) is developing a ‘Google Earth’ of cancer, revealing insights on a molecular scale to guide the development of more efficient drugs to target tumours. Josephine Bunch, principal investigator of the Rosetta project, offers an insight into this promising area of cancer research

Thumbnail image for A helping hand

A helping hand

Is augmented intelligence the key to achieving true digital transformation in pharma? Peter Crane outlines the need for a scientist-centric approach

Thumbnail image for A new horizon

A new horizon

The future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, however, we will see the dreamscape of an era-defining healthcare system and pharma industry, transformed by the stunning possibilities of AI

Thumbnail image for Oncology needs talent

Oncology needs talent

Pharma’s traditional R&D path is a business model under pressure. The ever-increasing demand for talented leadership in oncology is driving a need for collaboration

Thumbnail image for Sticking to it

Sticking to it

In an age where medication adherence apps are the contemporary equivalent of ‘a pill for every ill’, a fresh approach is desperately needed to break through the oversaturated market.

Thought Leadership

View all
Thumbnail image for Hidden gems

Hidden gems

How can big pharma and SME pharma work to mutual advantage and help patients with unmet medical need?

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download